ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

ACS Modifies Mammography Guidelines

August 5, 1983

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003